Background: Androgen therapy in the form of testosterone has been used for many years for the
management of low sexual desire in women and this often becomes a problem for women
during the menopause transition. Testosterone is currently recommended by the International
Menopause Society, the British Menopause Society and the National Institute for Health
and Care Excellence (NICE) for the treatment of diminished sexual desire that causes
the affected woman to experience significant distress.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to MaturitasAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2021 Published by Elsevier Inc.
